A pharmaceutical research centre in Abuja, Ben Amodu Firms and Research Center, Saturday said it has submitted drug samples to the Federal Government that have the efficacy to tackle Ebola virus.
The Chairman of the Centre, Pharmacist Ben Amodu, said the centre had produced drugs for the treatment of haemorrhagic fevers, which could also be used for Ebola virus.
He said the drugs have been submitted to the committee set up by the minister of health recently on Ebola adding that
“We gave the National Agency for Food and Drug Administration and Control (NAFDAC) and World Health Organization (WHO) samples of the drugs but the WHO later phoned and said they were not supposed to verify Ebola drugs. I gave samples to the committee set by the Minister of Health on Ebola virus and I hope that due process will be followed in
He said the Centre was into research of neglected tropical diseases, adding that the drugs
He said, “We got the drugs that cure Leishmaniasis and they have been previewed. We invented a drug, DAABS 2 which also cures Dangue fever which is viral Hemorrhagic fever and as you know Ebola is also a viral Hemorrhagic fever. Their symptoms include fever, intense weakness of the body system, vomiting, diarrhea, headache and internal and external bleeding. If you remove the bleeding aspect the disease becomes typhoid and
“The International Organisation for Scientific Research based in US, Japan and India have also previewed us for the management of hepatitis A,B,C,D,E and F, of which we have treated so many people. We have a drug that stops bleeding, including those from cervical cancer and uncontrolled menstrual flow. Our drug called SAABMAL was tested by the World Health Organization to have 97 per cent effectiveness in all forms of fever symptoms, including
“Another drug, TAABS 2 also has effects on fever while SAAB 6 has very strong Antioxidant and anti-inflammatory properties as confirmed by National Institute for Pharmaceutical Research and Development (NIPRD). Also one other drug SAAB is a very good immune booster”